cefixime and amikacin

cefixime has been researched along with amikacin in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armada, AA; Casimir, L; De Martino, MG; Debbag, R; Fernandez, C; Paganini, HR; Rodriguez-Brieshcke, MT; Sarkis, CM; Zubizarreta, PA	1
Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P	1
Lombardo, F; Obach, RS; Waters, NJ	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1

Reviews

1 review(s) available for cefixime and amikacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for cefixime and amikacin

Article	Year
Oral administration of cefixime to lower risk febrile neutropenic children with cancer. Cancer, 2000, Jun-15, Volume: 88, Issue:12 Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors	2000
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. Cancer, 2001, Apr-15, Volume: 91, Issue:8 Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome	2001

Article

Year

Oral administration of cefixime to lower risk febrile neutropenic children with cancer.

Cancer, 2000, Jun-15, Volume: 88, Issue:12

Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors

2000

Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.

Cancer, 2001, Apr-15, Volume: 91, Issue:8

Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome

2001

Other Studies

5 other study(ies) available for cefixime and amikacin

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013